Eosinophil diversity in asthma

Glenn Van Hulst,Hashini M Batugedara,Joseph Jorssen,Renaud Louis,Fabrice Bureau,Christophe J Desmet,Christophe J. Desmet
DOI: https://doi.org/10.1016/j.bcp.2020.113963
IF: 6.1
2020-09-01
Biochemical Pharmacology
Abstract:<p>Eosinophils are a type of granulated innate immune cells that have long been implicated in a specific type of asthma, referred to as eosinophilic asthma. Several immunotherapeutics that target and deplete eosinophils or limit their numbers are currently widely used and provide improved disease outcome in severe eosinophilic asthma. Current clinical results provide conclusive evidence of a generally detrimental role of eosinophils in asthma. Yet, a small but growing body of reports suggests that eosinophils may be more diverse than currently appreciated. In this review, we explore pre-clinical and clinical evidence that suggests the existence of eosinophil subsets with potentially distinct functional roles in asthma. We conclude by discussing state-of-the-art strategies for deciphering heterogeneity of this complex cell type, and argue this knowledge could translate into the improved personalized treatment of severe eosinophilic asthma.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?